PROSENSA HLDGS N V ORD SHS (NLD)
RNA
RNA was delisted on the 11th of February, 2015.
32 hedge funds and large institutions have $182M invested in PROSENSA HLDGS N V ORD SHS (NLD) in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 14 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
22% more call options, than puts
Call options by funds: $5.08M | Put options by funds: $4.15M
24% less funds holding
Funds holding: 42 → 32 (-10)
31% less capital invested
Capital invested by funds: $263M → $182M (-$81.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.81M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.85M |
| 3 |
DM
Deerfield Management
New York
|
+$3.72M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$894K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$663K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$3.33M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.86M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$2.21M |
| 4 |
JG
Jefferies Group
New York
|
-$1.14M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$690K |
RNA Hedge Fund Activity: Q3 2014 in Review
32 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in PROSENSA HLDGS N V ORD SHS (NLD) (RNA) for Q3 2014, worth a combined $182M — down 31% from $263M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of RNA and 4 opened new positions — a net loss of 10 holders — while 7 trimmed existing stakes and 15 added.
The largest buyer was Fidelity Investments, adding an estimated $4.81M. The largest seller was OrbiMed, exiting entirely with an estimated $3.33M sold.
- 32 institutional investors held PROSENSA HLDGS N V ORD SHS (NLD) (RNA) as of Q3 2014, down from 42 in Q2 2014.
- Funds reported $182M of PROSENSA HLDGS N V ORD SHS (NLD) stock for Q3 2014, down 31% quarter-over-quarter.
- 4 funds opened new PROSENSA HLDGS N V ORD SHS (NLD) positions in Q3 2014 and 14 closed out, a net change of -10 holders.
- The largest PROSENSA HLDGS N V ORD SHS (NLD) buyer in Q3 2014 was Fidelity Investments, an estimated $4.81M added.
- The largest PROSENSA HLDGS N V ORD SHS (NLD) seller in Q3 2014 was OrbiMed, an estimated $3.33M sold.
Based on aggregated 13F filings for Q3 2014.